If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Ethicon Endo-Surgery's expectations and projections. These statements are based on current expectations of future events. (This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. HARMONIC is a trademark of Ethicon Endo-Surgery, Inc. More information can be found at ©2008 Ethicon Endo-Surgery, Inc. The EnSeal device, cleared by the FDA in 2003, is capable of sealing vessels up to 7mm in diameter.Įthicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. The EnSeal family of devices combines high compression and controlled energy delivery to quickly create strong vessel seals. SurgRx was founded in 2002 and is located in Redwood City, Calif. Dave Clapper, President & CEO, SurgRx added, "We are looking forward to joining forces with Ethicon Endo-Surgery to offer these complementary technologies to even more patients worldwide." "The acquisition has the potential to expand the global availability of the EnSeal product line," said Rodney Perkins M.D., Chairman, Board of Directors, SurgRx. "Together, the combination of HARMONIC and EnSeal technologies will position us to better address many different procedure needs." "Ethicon Endo-Surgery and SurgRx share a commitment to innovation for the surgeons and patients who depend on our products," said Karen Licitra, Company Group Chairman and Worldwide Franchise Chairman, Ethicon Endo-Surgery. The transaction is subject to customary clearances, including the Hart-Scott-Rodino Antitrust Improvements Act and similar regulations in other countries. Terms of the agreement were not disclosed. The acquisition will provide Ethicon Endo-Surgery with a new energy platform, which complements its HARMONIC line of ultrasonic medical devices that have been used to perform open and laparoscopic procedures worldwide. CINCINNATI, Aug Ethicon Endo-Surgery announced today that it has entered into a definitive agreement to acquire SurgRx, a privately held developer of the advanced bipolar tissue sealing system used in the EnSeal family of devices.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |